Point72 Middle East FZE’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-38,607	Closed	-$106K	–	971
2023 Q2	$106K	Buy	38,607 +28,904	+298%	+$79.5K	﹤0.01%	694
2023 Q1	$30.5K	Buy	9,703 +7,787	+406%	+$24.5K	﹤0.01%	817
2022 Q4	$11.3K	Buy	+1,916	New	+$11.3K	﹤0.01%	1164